Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 DeFi Kingdoms DeFi Kingdoms +1,091.75%
#4 Black Phoenix Black Phoenix +335.28%
#5 aPriori aPriori +117.10%
#6 Bedrock Bedrock +74.91%
#7 Cysic Cysic +46.36%
#8 Prom Prom +40.32%
#9 Playnance Playnance +34.82%
#10 COTI COTI +33.90%
Coin of the day
Wrapped One Wrapped One
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Fresh2 Group Limited Fresh2 Group Limited

Fresh2 Group Limited

FRES
Peringkat dalam Saham #42683
Fresh2 Group Limited, a biotechnology company established in New York, New... Fresh2 Group Limited, a biotechnology company established in New York, New York, in 2010, officially adopted its current name in April 2023, having previously been known as AnPac Bio-Medical Science Co., Ltd. The company is primarily engaged in the research, development, promotion, and sale of advanced multi-cancer screening and detection tests within the People's Republic of China, leveraging its proprietary cancer differentiation analysis (CDA) technology and associated devices for corporate and life insurance clients. Beyond these core diagnostic offerings, Fresh2 Group provides comprehensive physical checkup packages and an array of technology services, including market research, design, software coding, development, and testing. The company also markets genetic testing kits and various skincare products. It owns several fundamental technology platforms and actively participates in further technological innovation and product distribution. Adding a unique dimension to its operations, Fresh2 Group also manages an e-commerce platform that facilitates connections between food suppliers and both supermarket operators and restaurant owners.
Harga Saham
$0.85
Terakhir disinkronkan: 2025-01-21
Kapitalisasi Pasar
$411.40
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Fresh2 Group Limited (FRES)

Kategori

Healthcare
Pendapatan untuk Fresh2 Group Limited (FRES)
Pendapatan pada Jun 2023 TTM: $1.64M
Menurut laporan keuangan terbaru dari Fresh2 Group Limited, pendapatan saat ini (TTM) adalah $1.64M. Pada tahun 2021, perusahaan menghasilkan pendapatan sebesar $2.79M penurunan dibandingkan dengan pendapatan pada tahun 2020 yang sebesar $2.97M. Pendapatan adalah jumlah total yang dihasilkan dari penjualan barang atau jasa. Tidak seperti laba, tidak ada pengeluaran yang dikurangkan.
Riwayat pendapatan Fresh2 Group Limited dari 2017 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Mengubah
2026 (TTM) $1.64M -5.98%
2022 $1.75M -37.49%
2021 $2.79M -5.89%
2020 $2.97M 91.09%
2019 $1.55M 0.32%
2018 $1.55M 81.73%
2017 $851.95K 0.00%
Pendapatan untuk perusahaan serupa atau pesaing
Perusahaan Pendapatan Perbedaan Pendapatan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B 768,932.17%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B 366,697.66%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B 615,816.94%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR